Under CD73-mediated adenosine activation, A2A receptor is highly expressed on the surface of tumor endothelial cells, stimulating VEGF production and significantly enhancing tumor angiogenesis, especially in early liver cancer. This evidence concerns the gene NT5E and liver cancer.